Biotech startups that raised Series A in San Francisco, United States
Updated 16 Nov 2026
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Company | City | Last round | Amount | Date |
|---|---|---|---|---|
| Probably Genetic | San Francisco | Series A | $12.0M | 2026-10-15 |
| Mithrl | San Francisco | Series A | $20.0M | 2026-09-15 |
| Medra AI | San Francisco | Series A | $52.0M | 2025-12-11 |
| Vivodyne | San Francisco | Series A | $40.0M | 2025-05-29 |
| SyntheX | San Francisco | Series A | $5.2M | 2025-05-23 |
| Inductive Bio | San Francisco | Series A | $25.0M | 2025-05-07 |
| Ouro Medicines | San Francisco | Series A | $120.0M | 2025-01-10 |
| Firefly Bio | San Francisco | Series A | $94.0M | 2024-02-15 |
8 rows of the CSV in 5 of its 18 columns.
- The 77 biotech startups in San Francisco, United States whose last round is Series A have raised $5.9B in total.
- 10 of them closed their most recent round in the last 12 months, $445.0M combined.
- The largest of those rounds is Estuary Biotherapeutics' $93.0M Series A, dated October 2026.
- Y Combinator is an investor in 2 of them, more than any other fund.
- Health care is the most common other sector, with 60 companies (78%).
- 36% were founded in 2020 or later; the median founding year is 2018.
- The most common team size is 11 to 50 employees (55% of companies with a recorded size).
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Newest rounds
4 of 77| Company | What they do | Sector | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|
| Probably Genetic | Probably Genetic develops treatments aimed at improving the lives of patients with severe, complex diseases. | Artificial intelligence | Series A | $12.0M | 2026-10-15 | $22.9M | Y Combinator, Khosla Ventures, TenOneTen Ventures +2 | 11 to 50 | 2018 |
| Mithrl | Mithrl is a software development company that builds custom NGS data workflows on demand. | Artificial intelligence | Series A | $20.0M | 2026-09-15 | $24.0M | Bonfire Ventures | 51 to 100 | 2023 |
| Medra AI | Medra AI builds an autonomous scientific experimentation platform that combines robotics with artificial intelligence. | Artificial intelligence | Series A | $52.0M | 2025-12-11 | $63.0M | PharmStars | 11 to 50 | 2021 |
| Aiolos Bio | Aiolos Bio is a biotech company developing therapies for respiratory diseases and immune conditions. | Biotech | Series A | $245.0M | 2023-10-24 | $245.0M | RA Capital Management, Atlas Venture, Forbion Capital Partners +2 | 11 to 50 | 2023 |
Table 1. Biotech startups that raised Series A in San Francisco, United States: the 4 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 77.
Largest rounds
Last 12 months| # | Company | What they do | Sector | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Medra AI | Medra AI builds an autonomous scientific experimentation platform that combines robotics with artificial intelligence. | Artificial intelligence | Series A | $52.0M | 2025-12-11 | $63.0M | PharmStars | 11 to 50 | 2021 |
| 2 | Mithrl | Mithrl is a software development company that builds custom NGS data workflows on demand. | Artificial intelligence | Series A | $20.0M | 2026-09-15 | $24.0M | Bonfire Ventures | 51 to 100 | 2023 |
| 3 | Probably Genetic | Probably Genetic develops treatments aimed at improving the lives of patients with severe, complex diseases. | Artificial intelligence | Series A | $12.0M | 2026-10-15 | $22.9M | Y Combinator, Khosla Ventures, TenOneTen Ventures +2 | 11 to 50 | 2018 |
Table 2. Biotech startups that raised Series A in San Francisco, United States: the 3 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most active investors
By companies backed| # | Investor | Type | Location | Companies | Share | Funded, 12 months | Latest |
|---|---|---|---|---|---|---|---|
| 1 | Y Combinator | Startup accelerator | Mountain View, United States | 2 | 3% | 1 | Probably Genetic |
| 2 | Khosla Ventures | Venture capital firm | Menlo Park, United States | 2 | 3% | 1 | Probably Genetic |
| 3 | Lux Capital | Venture capital firm | New York, United States | 2 | 3% | ||
| 4 | New Enterprise Associates | Venture capital firm | Menlo Park, United States | 2 | 3% | ||
| 5 | TenOneTen Ventures | Micro VC fund | Los Angeles, United States | 1 | 1% | 1 | Probably Genetic |
| 6 | Audrey Capital | Angel group | San Francisco, United States | 1 | 1% | 1 | Probably Genetic |
| 7 | Calm/Storm VC | Venture capital firm | Vienna, Austria | 1 | 1% | 1 | Probably Genetic |
| 8 | Bonfire Ventures | Venture capital firm | Los Angeles, United States | 1 | 1% | 1 | Mithrl |
| 9 | PharmStars | Startup accelerator | Boston, United States | 1 | 1% | 1 | Medra AI |
| 10 | MBX Capital | Venture capital firm | New York, United States | 1 | 1% | ||
| 11 | Kairos Ventures | Venture capital firm | Beverly Hills, United States | 1 | 1% | ||
| 12 | CS Venture Opportunities Fund | Private equity firm | New York, United States | 1 | 1% | ||
| 13 | Bison Ventures | Venture capital firm | Seattle, United States | 1 | 1% | ||
| 14 | SOSV | Venture capital firm | Princeton, United States | 1 | 1% | ||
| 15 | SOSV SF & NY (Fka IndieBio) | Venture capital firm | San Francisco, United States | 1 | 1% |
Table 3. Biotech startups that raised Series A in San Francisco, United States: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Sectors
| Sectors | Companies | Share | Total raised |
|---|---|---|---|
| Health care | 60 | 78% | $5.4B |
| Software | 17 | 22% | $525.1M |
| Artificial intelligence | 11 | 14% | $451.5M |
| Hardware | 2 | 3% | $26.5M |
| Cybersecurity | 1 | 1% | $4.4M |
| Energy | 1 | 1% |
Table 4. Biotech startups that raised Series A in San Francisco, United States by sector. Source: FundingWatcher. Data as of 16 November 2026.
Funding stage
| Funding stage | Companies | Share | Median last round |
|---|---|---|---|
| Series A | 77 | 100% | $23.0M |
Table 5. Biotech startups that raised Series A in San Francisco, United States by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Rounds by month
| Rounds by month | Companies | Share | Raised |
|---|---|---|---|
| October 2026 | 3 | 30% | $142.0M |
| September 2026 | 1 | 10% | $20.0M |
| August 2026 | 1 | 10% | $12.5M |
| March 2026 | 1 | 10% | $6.5M |
| January 2026 | 1 | 10% | $82.0M |
| December 2025 | 3 | 30% | $182.0M |
Table 6. Biotech startups that raised Series A in San Francisco, United States: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most recent round by year
| Most recent round by year | Companies | Share | Raised |
|---|---|---|---|
| 2026 | 7 | 9% | $263.0M |
| 2025 | 16 | 21% | $884.2M |
| 2024 | 5 | 6% | $188.0M |
| 2023 | 9 | 12% | $352.6M |
| 2022 | 7 | 9% | $201.0M |
| 2021 | 8 | 10% | $3.1B |
Table 7. Biotech startups that raised Series A in San Francisco, United States by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Founding year
| Founding year | Companies | Share |
|---|---|---|
| 2023 or later | 10 | 13% |
| 2020 to 2022 | 17 | 22% |
| 2015 to 2019 | 26 | 34% |
| 2010 to 2014 | 14 | 18% |
| Before 2010 | 9 | 12% |
Table 8. Biotech startups that raised Series A in San Francisco, United States by founding year. Source: FundingWatcher. Data as of 16 November 2026.
Team size
| Team size | Companies | Share |
|---|---|---|
| 1 to 10 | 26 | 35% |
| 11 to 50 | 41 | 55% |
| 51 to 100 | 6 | 8% |
| 251 to 500 | 1 | 1% |
| 10,001 or more | 1 | 1% |
Table 9. Biotech startups that raised Series A in San Francisco, United States by headcount. Source: FundingWatcher. Data as of 16 November 2026.
Method
- A company is on this list when Biotech is one of its sectors and its most recent funding round is Series A and its headquarters is in San Francisco, United States. On 16 November 2026 that is 77 companies.
- Stage, round, amount and date are those of the company's most recent funding round. Amounts are in US dollars as the source records them.
- The table prints the 4 newest rounds whose row is complete: a one-sentence description, a city, a named fund and an amount. The CSV carries all 77 rows: 9 have no round amount, 0 no city and 10 no website. The CSV carries domain, website, LinkedIn and the cached description sentence where present.
Sources, fields and exclusions of both files: Method.
Questions
- How many biotech startups in San Francisco, United States whose last round is Series A are on the list?
- 77, in the file dated 16 November 2026. 10 of them closed their most recent round in the last 12 months.
- What does the CSV contain?
- One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
- How much does the list cost?
- $29 one-time for all 77 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV download link, on the page after payment and by mail.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.